Full Text View
Tabular View
No Study Results Posted
Related Studies
Diagnosis of Tuberculosis Infection in HIV co-Infected Children (ThrasherIGRA)
This study is currently recruiting participants.
Verified by Case Western Reserve University, October 2008
First Received: October 5, 2007   Last Updated: October 6, 2008   History of Changes
Sponsors and Collaborators: Case Western Reserve University
Thrasher Research Fund
Information provided by: Case Western Reserve University
ClinicalTrials.gov Identifier: NCT00541294
  Purpose

Background: The TB and HIV epidemics are closely linked in developing countries, where 450,000 children die from HIV annually. TB is a major cause of death in HIV-infected children and is reversing gains made in child survival.

The traditional tuberculin skin test (TST) has limited diagnostic accuracy for detecting TB infection. Adult studies suggest that new blood-based diagnostic TB testing offers a quicker, more accurate way to diagnose TB infection. Such diagnostic testing may directly guide clinical management and preventive strategies in immune-suppressed HIV-infected children, who are at high risk of becoming TB diseased following infection. Data regarding the usefulness of these tests in children is currently limited.

Objective(s) and Hypothesis(es): The investigators hypothesize that blood-based TB diagnostic testing can accurately identify children with TB infection.

In a community with high rates of TB and HIV infection, the following specific aims will be investigated in HIV-infected and uninfected children:

  1. assess the agreement between the TST and blood-based diagnostic testing,
  2. compare the performance of the TST and blood-based diagnostic testing to a standardized history of TB exposure,
  3. measure the impact of age, nutritional and immune status on children's response to blood-based testing,
  4. describe factors that might modify children's response to testing over time, and 5) examine the effect of environmental exposures and previous vaccination on the TST, blood-based testing and other measures of immune responses to TB.

Potential Impact: The benefits of an accurate, rapid diagnostic test of TB infection in children include 1) timely institution of treatment for TB infection to prevent severe disease and mortality, and 2) preclusion of over diagnosis and treatment. Treatment of childhood TB infection also prevents future contagious adult disease, thus decreasing community transmission. Blood-based diagnostic testing may also be able to identify children that are more likely to become ill following TB infection. Therefore, blood-based diagnostic testing has great potential to improve TB control and the health of HIV-infected and uninfected children, their households and communities.


Condition
Latent Tuberculosis Infection
Tuberculosis
HIV Infections

Study Type: Observational
Study Design: Prospective
Official Title: Diagnosis of Tuberculosis Infection in HIV co-Infected Children

Resource links provided by NLM:


Further study details as provided by Case Western Reserve University:

Estimated Enrollment: 250
Study Start Date: October 2007
Estimated Study Completion Date: September 2010
Groups/Cohorts
B
M.tb unexposed HIV-infected and uninfected children <15 years of age
A
M.tb exposed HIV-infected and uninfected children <15 years of age

  Eligibility

Ages Eligible for Study:   3 Months to 15 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age less than 15 years
  • completion of informed consent

Exclusion Criteria:

  • less than 3 months of age
  • documented anemia
  • recent diagnosis of tuberculosis
  • receiving treatment for tuberculosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00541294

Contacts
Contact: Anna M Mandalakas, MD, MS 001.216.844.3224 anna.mandalakas@case.edu
Contact: Anneke C Hesseling, MD, MS 011.27. 21.9389173 annekeh@sun.ac.za

Locations
South Africa, Western Cape
Despond TuTu TB Centre, Stellenbosch University Recruiting
Tygerberg, Western Cape, South Africa, 07505
Contact: Felcity Stevens     27219389772     felicity@sun.ac.za    
Contact: Grace Bruintjies     27219389631     graceb@sun.ac.za    
Principal Investigator: Anneke C Hesseling            
Sponsors and Collaborators
Case Western Reserve University
Thrasher Research Fund
Investigators
Principal Investigator: Anna M Mandalakas, MD, MS Case Western Reserve University
Principal Investigator: Anneke C Hesseling, MD, MS Stellenbosch University
  More Information

No publications provided

Study ID Numbers: RES104272
Study First Received: October 5, 2007
Last Updated: October 6, 2008
ClinicalTrials.gov Identifier: NCT00541294     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Case Western Reserve University:
Tuberculosis
HIV
Diagnostics
Pediatrics

Study placed in the following topic categories:
Bacterial Infections
Virus Diseases
Gram-Positive Bacterial Infections
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Mycobacterium Infections
Tuberculosis
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
Bacterial Infections
Communicable Diseases
RNA Virus Infections
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Immune System Diseases
Acquired Immunodeficiency Syndrome
Infection
Actinomycetales Infections
Immunologic Deficiency Syndromes
Virus Diseases
Gram-Positive Bacterial Infections
HIV Infections
Sexually Transmitted Diseases
Lentivirus Infections
Mycobacterium Infections
Tuberculosis
Retroviridae Infections

ClinicalTrials.gov processed this record on July 06, 2009